The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually
updated evidence-based strategy for asthma management and prevention, which can be …

Abstract The Global Initiative for Asthma (GINA) was established in 1993 by the World
Health Organization and the US National Heart Lung and Blood Institute to improve asthma …

Low-income and middle-income countries (LMICs) bear a disproportionately high burden of
the global morbidity and mortality caused by chronic respiratory diseases (CRDs), including …

Asthma is the most common noncommunicable disease in children, and among the most
common in adults. The great majority of people with asthma live in low and middle income …

Asthma is a common chronic disease characterized by episodic or persistent respiratory
symptoms and airflow limitation. Asthma treatment is based on a stepwise and control-based …

Background To gain a global perspective on short-acting β2-agonist (SABA) prescriptions
and associated asthma-related clinical outcomes in patients with asthma, we assessed …

The 2020 National Asthma Education and Prevention Program Coordinating Committee
Expert Panel Working Group (NAEPP [2020 Focused Asthma Update]) guidelines and the …

Introduction Patients with asthma typically increase short-acting β 2-agonists (SABA) use
with worsening symptoms. Excessive SABA use may lead to a higher risk of adverse …

Background Expert national/global asthma management recommendations raise the issue
whether a safe threshold of short-acting beta-2 agonist (SABA) use without concomitant …

abstract Asthma is characterized by chronic airway inflammation, variable airway narrowing,
and sensory nerve irritation, which manifest as wheezing, dyspnea, chest tightness, and …